Pro Medicus Locks in A$28M AHN Renewal Lifting FY26 Renewals to A$125M
Pro Medicus locks in A$28M Allegheny Health Network renewal, pushing FY26 renewals to A$125M
Pro Medicus Limited (ASX: PME) has announced that Visage Imaging, Inc., its wholly-owned U.S. subsidiary, has signed a 5-year, A$28M contract renewal with Allegheny Health Network (AHN). The renewal also adds Visage 7 Workflow to the existing arrangement and was negotiated with increased minimums and an increased fee per transaction.
This is not a new client win. AHN has now renewed with Pro Medicus for a third consecutive contract term, reflecting approximately 10 years of continuous partnership. AHN operates across 14 hospitals, 2,500 beds, and more than 200 primary-care and specialty-care practices spanning over 300 clinical locations, serving 29 Pennsylvania counties as well as portions of New York, Ohio and West Virginia.
When big ASX news breaks, our subscribers know first
A decade-long partnership that keeps delivering
Third renewal in a row — what that signals
Each of AHN’s three contract renewals with Pro Medicus has come with improved commercial terms, and this latest agreement continues that pattern. The renewed contract carries increased minimums alongside a higher fee per transaction, both of which strengthen the revenue profile of the arrangement.
The transaction-based model structure means revenue has the potential to scale above the contracted minimums as AHN’s scan volumes grow, providing upside exposure beyond the baseline floor. After roughly a decade of continuous use, AHN’s decision to re-sign on progressively better terms points to deep platform adoption and a high degree of operational reliance on Pro Medicus’s technology.
Dr Sam Hupert, CEO — Pro Medicus
“We are very pleased to have played such a key role in AHN’s growth over the past 10 years. AHN has now renewed for a third contract term, reflecting the strength of our long-standing partnership and the value our platform continues to deliver across their organisation.”
Understanding Pro Medicus’s transaction-based revenue model
Rather than charging a flat annual licence fee, Pro Medicus earns revenue each time a scan or imaging study is processed through its platform. This is the core of its transaction-based model: the more scans a client processes, the more revenue Pro Medicus generates from that relationship.
For investors, this structure has a distinct advantage. As client scan volumes grow over time, whether due to population growth, expanded service lines, or higher patient throughput, revenue scales organically without requiring new contract negotiations. The “increased minimums” in this renewal means the baseline revenue floor has been raised, which reduces downside risk while the per-transaction upside remains intact.
The addition of Visage 7 Workflow to AHN’s existing arrangement is also worth noting. Visage 7 Workflow is a component of Pro Medicus’s broader Visage 7 platform suite, and its inclusion deepens AHN’s integration across the platform. Greater integration depth typically increases switching costs, making future renewals more likely and reinforcing long-term retention probability.
The key commercial terms of this renewal are summarised below.
| Contract Term | Contract Value | Model Type | New Addition | Renewal Number |
|---|---|---|---|---|
| 5 years | A$28M | Transaction-based (increased minimums + increased fee per transaction) | Visage 7 Workflow | Third renewal |
The next major ASX story will hit our subscribers first
A$125M in FY26 renewals reinforces PME’s retention track record
The AHN deal lifts Pro Medicus’s total contract renewals for the financial year to A$125M. That cumulative figure reflects a consistent pattern of existing clients not just staying on the platform but re-signing on improved commercial terms, a meaningful indicator of platform value and client satisfaction.
Dr Sam Hupert, CEO — Pro Medicus
“This contract brings our total renewals for the financial year to A$125M, maintaining our track record of client retention. This underpins our belief that our solution provides unparalleled return on investment from both a financial and a clinical perspective.”
For investors, the combination of locked-in contracted revenue and transactional upside above the minimums provides a durable, predictable earnings base. Renewal momentum of this scale, with clients re-signing on progressively stronger terms, supports revenue visibility well into future financial years.
Key highlights of the AHN renewal are as follows:
- 5-year contract term
- A$28M contract value
- Third consecutive renewal with AHN
- Inclusion of Visage 7 Workflow
- Increased minimums and increased fee per transaction
- A$125M in total FY26 renewals to date
Don’t Miss the Next Healthcare Stock Breakout
Big News Blast delivers FREE breaking ASX healthcare news directly to your inbox within minutes of release, complete with in-depth analysis. Join 20,000+ investors already staying ahead of the market. Click the “Free Alerts” button at StockWire X to get the next market-moving announcement the moment it drops.